Miconazole Therapy for Fungal Meningitis
- 1 July 1978
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 35 (7), 443-447
- https://doi.org/10.1001/archneur.1978.00500310045009
Abstract
• Eight patients with fungal meningitis (5 with the coccidioidal type, 2 with cryptococcal, and 1 with histoplasmosis) were treated with intravenous (IV) and intrathecal (IT) miconazole after previous therapy with amphotericin B proved unsuccessful. Miconazole was well tolerated with both IV and IT administration. The CSF concentration of miconazole one hour after an IV infusion of 800 mg was 0.1 to 0.3 μ/ml. When 20 mg of miconazole was administered intrathecally via lumbar injection in patients with coccidioidal meningitis, 6.5, 2.4, 0.77, and 0.24 μg/ml, respectively, was found in the CSF at the cisternal level at 12, 24, 48, and 72 hours, respectively. Miconazole is apparently an effective fungistatic drug of low toxicity and is a potentially useful agent in the treatment of systemic mycoses and fungal meningitis, in particular.This publication has 7 references indexed in Scilit:
- Side Effects of Miconazole for Systemic MycosesNew England Journal of Medicine, 1977
- Unusual Serum Lipoprotein Abnormality Induced by the Vehicle of MiconazoleNew England Journal of Medicine, 1977
- Chemotherapy of Systemic MycosesNew England Journal of Medicine, 1974
- Miconazole, a Broad-Spectrum Antimycotic Agent with Antibacterial ActivityChemotherapy, 1972
- Cryptococcosis of the central nervous system: Epidemiological, clinical, and therapeutic featuresJournal of Neurology, Neurosurgery & Psychiatry, 1970
- Amphotericin B ToxicityAnnals of Internal Medicine, 1969
- COCCIDIOIDAL MENINGITIS - USE OF AMPHOTERICIN B IN TREATMENT1961